Dimensional Fund Advisors
TARO

Dimensional Fund Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Dimensional Fund Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-519,684
Closed -$22M – 3427
2024
Q1 		$22M Sell
519,684
-25,998
-5% -$1.1M 0.01% 1931
2023
Q4 		$22.8M Sell
545,682
-4,226
-0.8% -$156K 0.01% 1929
2023
Q3 		$20.7M Sell
549,908
-2,254
-0.4% -$84.6K 0.01% 1900
2023
Q2 		$20.9M Sell
552,162
-20,743
-4% -$651K 0.01% 1905
2023
Q1 		$13.9M Buy
572,905
+2,535
+0.4% +$73.9K ﹤0.01% 2081
2022
Q4 		$16.6K Buy
570,370
+3,175
+0.6% +$94.2K ﹤0.01% 1957
2022
Q3 		$17M Buy
567,195
+11,582
+2% +$399K 0.01% 1913
2022
Q2 		$20.1M Buy
555,613
+20,984
+4% +$800K 0.01% 1865
2022
Q1 		$23.1M Buy
534,629
+17,947
+3% +$839K 0.01% 1893
2021
Q4 		$25.9M Sell
516,682
-6,031
-1% -$338K 0.01% 1849
2021
Q3 		$33.3M Buy
522,713
+673
+0.1% +$46.6K 0.01% 1714
2021
Q2 		$37.6M Buy
522,040
+19,547
+4% +$1.44M 0.01% 1667
2021
Q1 		$37.1M Buy
502,493
+23,499
+5% +$1.78M 0.01% 1664
2020
Q4 		$35.2M Buy
478,994
+4,832
+1% +$311K 0.01% 1653
2020
Q3 		$26M Buy
474,162
+13,275
+3% +$826K 0.01% 1704
2020
Q2 		$30.6M Buy
460,887
+10,884
+2% +$730K 0.01% 1589
2020
Q1 		$27.5M Buy
450,003
+52,079
+13% +$3.86M 0.01% 1531
2019
Q4 		$35M Buy
397,924
+9,001
+2% +$759K 0.01% 1726
2019
Q3 		$29.3M Buy
388,923
+35,700
+10% +$2.9M 0.01% 1792
2019
Q2 		$30.2M Buy
353,223
+39,415
+13% +$3.9M 0.01% 1819
2019
Q1 		$33.9M Buy
313,808
+12,827
+4% +$1.28M 0.01% 1745
2018
Q4 		$25.5M Buy
300,981
+31,555
+12% +$3.04M 0.01% 1852
2018
Q3 		$26.5M Buy
269,426
+10,355
+4% +$1.12M 0.01% 1956
2018
Q2 		$30M Sell
259,071
-1,601
-0.6% -$176K 0.01% 1869
2018
Q1 		$25.7M Buy
260,672
+20,407
+8% +$2.07M 0.01% 1912
2017
Q4 		$25.2M Buy
240,265
+17,955
+8% +$1.97M 0.01% 1940
2017
Q3 		$25.1M Buy
222,310
+43,918
+25% +$4.78M 0.01% 1910
2017
Q2 		$20M Buy
178,392
+46,570
+35% +$5.26M 0.01% 2026
2017
Q1 		$15.4M Buy
131,822
+13,625
+12% +$1.51M 0.01% 2123
2016
Q4 		$12.4M Buy
118,197
+3,830
+3% +$401K 0.01% 2210
2016
Q3 		$12.6M Buy
114,367
+9,081
+9% +$1.2M 0.01% 2152
2016
Q2 		$15.3M Buy
105,286
+4,432
+4% +$628K 0.01% 2018
2016
Q1 		$14.4M Buy
100,854
+8,814
+10% +$1.25M 0.01% 2029
2015
Q4 		$14.2M Buy
92,040
+500
+0.5% +$73K 0.01% 2031
2015
Q3 		$13.1M Buy
91,540
+16,098
+21% +$2.25M 0.01% 2058
2015
Q2 		$10.8M Buy
75,442
+32,198
+74% +$4.59M 0.01% 2230
2015
Q1 		$6.1M Buy
43,244
+7,826
+22% +$1.2M ﹤0.01% 2469
2014
Q4 		$5.25M Buy
35,418
+9,987
+39% +$1.47M ﹤0.01% 2541
2014
Q3 		$3.91M Buy
25,431
+2,046
+9% +$308K ﹤0.01% 2626
2014
Q2 		$3.28M Buy
23,385
+4,747
+25% +$527K ﹤0.01% 2711
2014
Q1 		$2.07M Buy
18,638
+14,217
+322% +$1.55M ﹤0.01% 2827
2013
Q4 		$437K Buy
4,421
+2,492
+129% +$216K ﹤0.01% 3197
2013
Q3 		$147K Buy
+1,929
New +$125K ﹤0.01% 3343

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $3.3B AUM 20.27% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Dimensional Fund Advisors's TARO Position: Q2 2024 in Review

Dimensional Fund Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 519,684 shares — an estimated $22M sold.

Dimensional Fund Advisors first reported a position in TARO in Q3 2013 and held it in 43 quarters. The position peaked at $37.6M in Q2 2021. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Dimensional Fund Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 519,684 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $22M.
  • Dimensional Fund Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2013 and held it in 43 quarters.
  • Dimensional Fund Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $37.6M in Q2 2021.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Dimensional Fund Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.